Editors
Mariano Provencio Pulla
Medical Oncology Department, Hospital Universitario Puerta de Hierro, Madrid, Spain
Contributors
Chapter 1 - Cardiac Complications of Cancer and Anticancer Treatment
G. Griguolo - Department of Surgery, Oncology and Gastroenterology, University of Padova, Padova, Italy; Division of Medical Oncology 2, Istituto Oncologico Veneto, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), Padova, Italy
V. Guarneri - Department of Surgery, Oncology and Gastroenterology, University of Padova, Padova, Italy; Division of Medical Oncology 2, Istituto Oncologico Veneto, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), Padova, Italy
Chapter 2 - Venous Thromboembolism in Cancer Patients
J. Chiramel - Department of Medical Oncology, The Christie NHS Foundation Trust, Manchester, UK
Z. Salih - Department of Medical Oncology, The Christie NHS Foundation Trust, Manchester, UK
R. Califano - Department of Medical Oncology, The Christie NHS Foundation Trust, Manchester, UK; Department of Medical Oncology, University Hospital of South Manchester NHS Foundation Trust, Manchester, UK
Chapter 3 - Superior Vena Cava Syndrome
V. Foy* - The Christie NHS Foundation Trust, Manchester, UK
R. Kurup* - The Christie NHS Foundation Trust, Manchester, UK
*co-first authorsChapter 4 - Complications of Central Venous Devices
N. Volkov - Saint-Petersburg Scientifical Practical Center of Specialized Kinds of
Medical Care (Oncological), St-Petersburg, Russian Federation
F. Moiseenko - Saint-Petersburg Scientifical Practical Center of Specialized Kinds of
Medical Care (Oncological), St-Petersburg, Russian Federation
Chapter 5- Septic Shock
F. Morgillo - Faculty of Medicine, Second University of Naples, Naples, Italy
E. Martinelli - Faculty of Medicine, Second University of Naples, Naples, Italy
T. Troiani - Faculty of Medicine, Second University of Naples, Naples, Italy
Chapter 6 - Extravasation of Chemotherapy
M. Unseld - Department of Internal Medicine I, Section of Oncology, Medical University of Vienna, Austria
C. Thallinger - Department of Internal Medicine I, Section of Oncology, Medical University of Vienna, Austria
Chapter 7 - Spinal Cord Compression
E.B. Köksoy - Ankara University School of Medicine, Department of Medical Oncology, Ankara, Turkey
Y. Ürün - Ankara University School of Medicine, Department of Medical Oncology, Ankara, Turkey
Chapter 8 - Complications of Brain Metastases
L. de Mattos-Arruda - Cancer Research UK Cambridge Institute, University of Cambridge, Cambridge, UK; Vall d’Hebron Institute of Oncology, Vall d’Hebron University Hospital, Barcelona, Spain; Universitat Autònoma de Barcelona, Barcelona, Spain
M. Preusser - Department of Medicine I and Comprehensive Cancer Center CNS Unit, Medical University of Vienna, Vienna, Austria
Chapter 9 - Renal Failure and Urological Emergencies in Cancer Patients
M. Mediano - Virgen del Rocio University Hospital, Seville, Spain
I. Duran - Virgen del Rocio University Hospital, Seville, Spain
Chapter 10 - Hypercalcaemia
M. Strijbos - Medical Oncology, AZ Klina, Iridium Cancer Network, Antwerp, Belgium
K. Punie - Medical Oncology, Leuven University Hospitals, Leuven, Belgium
Chapter 11 - Tumour Lysis Syndrome
K. Punie - Medical Oncology, Leuven University Hospitals, Leuven, Belgium
M. Strijbos - Medical Oncology, AZ Klina, Iridium Cancer Network, Antwerp, Belgium
Chapter 12 - Other Endocrine and Metabolic Complications of Advanced Cancer
M. Magalhães - Service of Medical Oncology, Centro Hospitalar do Porto - Unit for Multidisciplinary Research in Biomedicine, Institute of Biomedical Sciences Abel Salazar, University of Porto, Porto, Portugal
J. Febra - Service of Medical Oncology, Centro Hospitalar do Porto - Unit for Multidisciplinary Research in Biomedicine, Institute of Biomedical Sciences Abel Salazar, University of Porto, Porto, Portugal
A. Araújo - Service of Medical Oncology, Centro Hospitalar do Porto - Unit for Multidisciplinary Research in Biomedicine, Institute of Biomedical Sciences Abel Salazar, University of Porto, Porto, Portugal
Chapter 13 - Dyspnoea and Respiratory Failure
P. N. Aguiar, Jr - Department of Oncology and Haematology, Division of Medical Oncology, Federal University of São Paulo, São Paulo, Brazil
H. Tadokoro - Department of Oncology and Haematology, Division of Medical Oncology, Federal University of São Paulo, São Paulo, Brazil
R. Andrade de Mello - Department of Biomedical Sciences and Medicine, Division of Medical Oncology, University of Algarve, Faro, Portugal; Department of Medicine, Faculty of Medicine, University of Porto, Porto, Portugal; Department of Medical Oncology, Centro Oncológico São Mateus, Ceará Cancer Institute, Fortaleza, Brazil
Chapter 14 - Pulmonary Infections in Cancer
T. Padua - Department of Medical Oncology, Federal University of São Paulo,
São Paulo, Brazil
H. Tadokoro - Department of Medical Oncology, Federal University of São Paulo,
São Paulo, Brazil
R. Andrade de Mello - Department of Biomedical Sciences and Medicine, Division of Medical Oncology, University of Algarve, Faro, Portugal; Department of Medicine,
Faculty of Medicine, University of Porto, Porto, Portugal; Department of Medical Oncology, Centro Oncológico São Mateus, Ceará Cancer Institute, Fortaleza, Brazil
Chapter 15 - Haemoptysis and Intractable Hiccups
E. Castañon Alvarez - Phase I – Early Clinical Trials Unit, Oncology Department, Antwerp University Hospital and Center for Oncological Research, Antwerp University, Antwerp, Belgium
K. Papadimitriou - Phase I – Early Clinical Trials Unit, Oncology Department, Antwerp University Hospital and Center for Oncological Research, Antwerp University, Antwerp, Belgium
C. Rolfo - Phase I – Early Clinical Trials Unit, Oncology Department, Antwerp University Hospital and Center for Oncological Research, Antwerp University, Antwerp, Belgium
Chapter 16 - Nausea and Vomiting
G. Mountzios - University of Athens School of Medicine, Athens, Greece
M. Petrova - MHAT Nadezhda (Multiprofile Hospital of Active Treatment), Sofia, Bulgaria
Chapter 17 - Mucositis
L. Poulsen - Department of Oncology, Aalborg University Hospital, Aalborg, Denmark
C. Qvortrup - Department of Oncology, Odense University Hospital, Odense, Denmark
Chapter 18 - Diarrhoea
D. Pérez-Callejo - Medical Oncology Service, Hospital Universitario Puerta de Hierro Majadahonda, Madrid, Spain
V. Calvo - Medical Oncology Service, Hospital Universitario Puerta de Hierro Majadahonda, Madrid, Spain
Chapter 19 - Abdominal Infections in Neutropaenic Patients
V. Ballová - Národný onkologický ústav, Hemato-oncological Department, Bratislava, Slovakia
Chapter 20 - Anaemia in Cancer
T. Troiani - Faculty of Medicine, Second University of Naples, Naples, Italy
Chapter 21 - Febrile Neutropaenia in Cancer Patients
M. Alonso - Medical Oncology Department, University Hospital Virgen del Rocio, Seville, Spain
J. Corral - Medical Oncology Department, University Hospital Virgen del Rocio, Seville, Spain
Chapter 22 - Immune–Haematological Emergencies in Cancer Patients
E. Martinelli - Faculty of Medicine, Second University of Naples, Naples, Italy
C. Cardone - Faculty of Medicine, Second University of Naples, Naples, Italy
V. Sforza - Faculty of Medicine, Second University of Naples, Naples, Italy
Chapter 23 - Bleeding Disorders
E. Martinelli - Faculty of Medicine, Second University of Naples, Naples, Italy
V. Sforza - Faculty of Medicine, Second University of Naples, Naples, Italy
C. Cardone - Faculty of Medicine, Second University of Naples, Naples, Italy
Chapter 24 - Management of Cancer Pain
M. A. Öztürk - Department of Medical Oncology, Marmara University Faculty of Medicine, Istanbul, Turkey
O. Yazıcı - Department of Medical Oncology, Ankara Numune Research & Education Hospital, Ankara, Turkey
A. A. Sag - Division of Interventional Radiology, Department of Radiology, Koc University School of Medicine, Istanbul, Turkey
Chapter 25 - Psychological Complications
N. Blanco-Piñero - Department of Psychiatry, Faculty of Medicine, University of Seville, Seville, Spain
E. Nogales-Fernández - Medical Oncology Department, Hospital Universitario Virgen Macarena, Seville, Spain
L. de la Cruz-Merino - Medical Oncology Department, Hospital Universitario Virgen Macarena, Seville, Spain
Declaration of Interest
Chapter 1: Dr Griguolo has reported no conflicts of interest.
Dr Guarneri has reported no conflicts of interest.
Chapter 2: Dr Chiramel has reported no conflicts of interest.
Dr Salih has reported no conflicts of interest.
Dr Califano has reported no conflicts of interest.
Chapter 3: Dr Foy has reported no conflicts of interest.
Dr Kurup has reported no conflicts of interest.
Chapter 4: Dr Volkov has reported no conflicts of interest.
Dr Moiseenko has reported no conflicts of interest.
Chapter 5: Dr Morgillo has reported no conflicts of interest.
Dr Martinelli has reported no conflicts of interest.
Dr Troiani has reported no conflicts of interest.
Chapter 6: Dr Unseld has reported no conflicts of interest.
Dr Thallinger has reported no conflicts of interest.
Chapter 7: Köksoy has reported no conflicts of interest.
Dr Ürün has reported no conflicts of interest.
Chapter 8: Dr de Mattos-Arruda has reported no conflicts of interest.
Professor Preusser has declared research grants from: Roche, GlaxoSmithKline, Boehringer Ingelheim; honoraria from: Roche, GlaxoSmithKline, Bristol-Myers Squibb, Mundipharma; and travel grants from: Roche, Bristol-Myers Squibb.
Chapter 9: Dr Mediano has reported no conflicts of interest.
Dr Duran has reported no conflicts of interest.
Chapter 10: Dr Strijbos has reported no conflicts of interest.
Dr Punie has reported no conflicts of interest.
Chapter 11: Dr Punie has reported no conflicts of interest.
Dr Strijbos has reported no conflicts of interest.
Chapter 12: Dr Magalhães has reported no conflicts of interest.
Dr Febra has reported no conflicts of interest.
Dr Araújo has attended advisory boards for AstraZeneca, Eli Lilly Oncology, Hospira, Merck, Astellas and Bayer. He also declared being a member of the speaker’s bureau of Eli Lilly Oncology and Astellas.
Chapter 13: Dr Aguiar has reported no conflicts of interest.
Dr Tadokoro has reported no conflicts of interest.
Professor Andrade de Mello has served on advisory boards for Pfizer.
Chapter 14: Dr Padua has reported no conflicts of interest.
Dr Tadokoro has reported no conflicts of interest.
Professor Andrade de Mello has served on advisory boards for Pfizer.
Chapter 15: Dr Castañon Alvarez has reported no conflicts of interest.
Dr Papadimitriou has reported no conflicts of interest.
Professor Rolfo has declared that he is part of a speakers’ bureau for Novartis.
Chapter 16: Dr Mountzios has reported no conflicts of interest.
Dr Petrova has reported no conflicts of interest.
Chapter 17: Dr Poulsen has reported no conflicts of interest.
Dr Qvortrup has reported no conflicts of interest.
Chapter 18: Dr Pérez-Callejo has reported no conflicts of interest.
Dr Calvo has reported no conflicts of interest.
Chapter 19: Dr Ballová has reported no conflicts of interest.
Chapter 20: Dr Troiani has reported no conflicts of interest.
Chapter 21: Dr Alonso has reported no conflicts of interest.
Dr Corral has reported no conflicts of interest.
Chapter 22: Dr Martinelli has reported no conflicts of interest.
Dr Cardone has reported no conflicts of interest.
Dr Sforza has reported no conflicts of interest.
Chapter 23: Dr Martinelli has reported no conflicts of interest.
Dr Sforza has reported no conflicts of interest.
Dr Cardone has reported no conflicts of interest.
Chapter 24: Dr Öztürk has reported no conflicts of interest.
Dr Yazıcı has reported no conflicts of interest.
Dr Sag has reported no conflicts of interest.
Chapter 25: Dr Blanco-Piñero has reported no conflicts of interest.
Dr Nogales-Fernández has reported no conflicts of interest.
Dr de la Cruz-Merino has reported no conflicts of interest.
